"They should (nd apologies if I am wrong) start with main page saying "
a) the result will most likely conduct us to federal approval
b) if that achieved the result will be act with a X million market
c) the fact we didn't achieved full target means we are not participating of X million market
d) we target have this procedure ready to the market around month/year
e) the forecast profit will be approximately …. million a year."
That's pretty much the format SRX posted their last 2 trial results. Very fair and clear to every investor. Why does the ASX allow indeterminate dribble to be announced by biotech companies? They need more biotech expertise.
Ann: LVAD Results Webcast Presentation, page-6
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.13 |
Change
0.035(3.21%) |
Mkt cap ! $1.284B | |||
| Open | High | Low | Value | Volume |
| $1.09 | $1.13 | $1.07 | $3.910M | 3.535M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 27197 | $1.11 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.13 | 43578 | 3 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |